Globus Medical Inc (GMED) Q3 2024 Earnings Call Highlights: Record Revenue and Strategic Growth ...

By Yahoo! Finance | Nov 6, 2024 at 02:21 AM EST

The company targeted cost redundancies and facility consolidations to drive EBITDA margins. NuVasive's sales force integration with Globus Medical's robotic systems is progressing well. The FDA warning letter had minimal impact on sales. Globus Medical is confident in the capital equipment environment despite new competitors.

Did you find this insightful?

Bad

Just Okay

Amazing

We are preparing, please wait

New Alert

Select an alert type

Sentiment Spike

Send email alert if news sentiment changes significantly

Mentions Spike

Send email alert if has a surge in mentions

Choose sentiment spike or mentions spike or both to receive email alerts and app notification for the selected stock.
Note: Please be aware that you will receive an email only once a day, around 8:00 AM (EST), in the event of any spike.
In future if you don't want to receive any email then delete stocks added into alert section.